Evidence Partners® Inc. announced today, August 9th, that it has closed a growth financing round worth $20 million. The funding comes from Thomwest Ventures, Pender Ventures, and Export Development Canada. Evidence Partners is known as a leader in artificial intelligence (AI)-based automated literature review software with their DistillerSR™ platform. The software automates the tedious and time-consuming process of literature review.
According to Peter O’Blenis, CEO of Evidence Partners, “This new funding will allow us to further accelerate product innovation, enabling our customers to continue to bring life-changing medical products and research to market faster. As the market leader for AI-enabled literature review software, the company will further invest in go-to-market initiatives to ensure that the global research community is aware of and can access this important technology.”
To read more, click here.
(Source: PR Newswire, August 9th, 2022)